N-acetylcysteine as a potential treatment for COVID-19.

Jorge-Aarón, Rangel-Méndez; Rosa-Ester, Moo-Puc

Jorge-Aarón, Rangel-Méndez; Rosa-Ester, Moo-Puc.

Jorge-Aarón RM; Unidad de Investigación Biomédica, Unidad Médica de Alta Especialidad, Hospital de Especialidades del Centro Médico Nacional 'Ignacio García Téllez', Instituto Mexicano del Seguro Social, Calle 41 No. 439, Col. Industrial, 97150 Mérida, Yucatán, México.
Rosa-Ester MP; Unidad de Investigación Biomédica, Unidad Médica de Alta Especialidad, Hospital de Especialidades del Centro Médico Nacional 'Ignacio García Téllez', Instituto Mexicano del Seguro Social, Calle 41 No. 439, Col. Industrial, 97150 Mérida, Yucatán, México.

Future Microbiol ; 15: 959-962, 2020 07.

Article in English | MEDLINE | ID: covidwho-771610

Subject(s)

Acetylcysteine/therapeutic use; Betacoronavirus/drug effects; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Acetylcysteine/pharmacology; Angiotensin II/drug effects; Antioxidants/therapeutic use; Betacoronavirus/physiology; COVID-19; Coronavirus Infections/virology; Cytokines/metabolism; Humans; Oxidative Stress/drug effects; Pandemics; Pneumonia, Viral/virology; SARS-CoV-2; Virus Internalization/drug effects

Keywords

COVID-19; N-acetylcysteine; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Acetylcysteine / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Future Microbiol Journal subject: Microbiology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google